Patents Assigned to Fermenta Biotech Limited
  • Patent number: 11718640
    Abstract: The present invention discloses an improved process for extracting cholesterol in high yield and purity from fish oil waste residue. The so obtained cholesterol of pharmaceutical grade is useful as a precursor for the preparation of vitamin D3.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: August 8, 2023
    Assignee: FERMENTA BIOTECH LIMITED
    Inventors: Anupama Datla, Prashant Nagre, Jagdish Tamore, Sreenath Trivikram, Gajanan Degaonkar
  • Patent number: 11629309
    Abstract: The present invention discloses solvent free process for extracting cholesterol free of impurities from milk fat. The so isolated cholesterol is useful for the further preparation of vitamin D3. The present invention further provides pharmaceutical grade cholesterol from milk fat of high purity.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: April 18, 2023
    Assignee: FERMENTA BIOTECH LIMITED
    Inventors: Anupama Datla, Prashant Nagre, Jagdish Tamore, Sreenath Trivikram, Amol Shirsath
  • Publication number: 20110287509
    Abstract: The present invention provides a stable and viable biocatalyst with high activity and operational stability and method of immobilization thereof. The immobilization process is based on the principle of entrapment of partially purified enzyme precipitate which is simultaneously aggregated by cross linking agent like glutaraldehyde and further entrapped in a combination of natural polymer like gelatin and synthetic polymer like polyvinyl alcohol with effective gelation under mild conditions of temperature and pH, resulting in a stable biocatalyst. The enzymes immobilized by the above process include Penicillin acylase from rE. coli RE III (pKA18), Novel Penicillin acylase from Achromobacter sp (CCM4834) expressed in rE. coli BL21 (pK1P1) CCM 7394 and rE. coli RE III (pKX1P1).
    Type: Application
    Filed: November 14, 2008
    Publication date: November 24, 2011
    Applicants: Mikrobiologicky Ustav Avcr V.V.I., Fermenta Biotech Limited
    Inventors: Anupama Datla, Williams Rajasekar Vyasarayani, Trupti Krishnakant Ashar, Kyslik Pavel, Becka Stanislav
  • Patent number: 8039604
    Abstract: The invention consists in a nucleotide sequence having the size of (2646) bp, wherein the order of nucleotides is identical to the order of the nucleotide sequence encoding penicillin acylase from Achromobacter sp. CCM 4824 (formerly Comamonas testosteroni CCM 4824), eventually of the fragments of this sequence having the length of at least 150 nucleotides. The sequence can be used in the formation of a DNA construct, eventually the construct having at least one regulatory sequence regulating the expression of the gene and the production of a polypeptide with the penicillin acylase activity. The sequence can form part of a recombinant expression vector, which consists of the above-mentioned construct, promoter, translational start signal, translational and transcriptional stop signal. Further, the invention concerns a recombinant host cell, containing the nucleic acid construct carried by the vector or integrated into the cell chromosome, and the E.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: October 18, 2011
    Assignees: Fermenta Biotech Limited, Mikrobiologicky UTSAV AV CR
    Inventors: Pavel Kyslik, Vaclav Stepanek, Lenka Hollerova, Stanislav Becka, Vyasarayani Williams Rajasekar, Datla Anupama, Kamila Plhackova, Jaroslav Marsalek
  • Publication number: 20100112673
    Abstract: The invention consists in a nucleotide sequence having the size of (2646) bp, wherein the order of nucleotides is identical to the order of the nucleotide sequence encoding penicillin acylase from Achromobacter sp. CCM 4824 (formerly Comamonas testosteroni CCM 4824), eventually of the fragments of this sequence having the length of at least 150 nucleotides. The sequence can be used in the formation of a DNA construct, eventually the construct having at least one regulatory sequence regulating the expression of the gene and the production of a polypeptide with the penicillin acylase activity. The sequence can form part of a recombinant expression vector, which consists of the above-mentioned construct, promoter, translational start signal, translational and transcriptional stop signal. Further, the invention concerns a recombinant host cell, containing the nucleic acid construct carried by the vector or integrated into the cell chromosome, and the E.
    Type: Application
    Filed: May 15, 2007
    Publication date: May 6, 2010
    Applicants: Fermenta Biotech Limited, Mikrobiologicky UTSAV AV CR v.v.i.
    Inventors: Pavel Kyslik, Vaclav Stepanek, Lenka Hollerova, Stanislav Becka, Vyasarayani Williams Rajasekar, Datla Anupama, Kamila Plhackova, Jaroslav Marsalek
  • Patent number: 7094920
    Abstract: A process is described for the stereospecific preparation of an ester of formula (I): wherein * signifies the (R) stereoisomer; R1 is selected from C1-6 alkyl, preferably ethyl; and R2 is hydrogen, a protecting group or a leaving group which process comprises reaction of a nitrile of formula (II): wherein * signifies the (R) stereoisonomer; and Ph is the phenyl group C6 H5 with a solution of an inorganic acid in an alcohol and optional conversion of the compound of formula (I) wherein R2 is H so prepared to any other desired compound of formula (I) by standard methods in the art. The compounds of formula (I) are chiral esters, useful as intermediates in the synthesis of the family of acetylcholine esterase (ACE) inhibitors known as “prils”, such as lisinopril, cilazapril, enalapril, benazepril, ramipril, delapril, enalaprilat, imidapril, spirapril, trandolapril and others.
    Type: Grant
    Filed: November 21, 2003
    Date of Patent: August 22, 2006
    Assignee: Fermenta Biotech Limited
    Inventor: Raveendra Khandurao Tikare